Metaxalone
- Product NDC
- 70934-286
- 11-digit product format
- 709340286
- Labeler code
- 70934
- Product ID
- 70934-286_b1044e47-6232-bd99-e053-2a95a90aadb5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metaxalone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA204770
- Marketing category
- ANDA
- Marketing start
- 2019-02-12
- Marketing end
- 0000-00-00
- Substance
- METAXALONE
- Active strength
- 800 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-286-10 | 70934028610 | 10 TABLET in 1 BOTTLE, PLASTIC (70934-286-10) | 10 tablet | 2019-02-12 | 0000-00-00 | No | No | Current |
| 70934-286-20 | 70934028620 | 20 TABLET in 1 BOTTLE, PLASTIC (70934-286-20) | 20 tablet | 2019-06-19 | 0000-00-00 | No | No | Current |